Posted October 18, 2019
Be Well MD is engaging in clinical research to support the health and wellness of seniors into the future.
We’re happy to announce we’ve been selected to participate in a landmark trial focused on immunotherapy. We’re moving quickly to recruit participants as the pre-screening timeframe is short. Enrollment begins next Monday and lasts just a few days.
The primary objective of this study is to assess the effect of the investigational drug, RTB101, for preventing respiratory illness associated with respiratory tract infections. As we get older our bodies don’t respond as well to infections as they once did. This means that even a common cold can turn into a serious health problem. This is especially true for seniors, who may be at a higher risk of developing an RTI, which is a leading cause of hospitalization among seniors.
Download this flier with more details on this study. If you meet the (2) qualifications noted on the flier, we invite you to participate. Please pass this along to family and friends, too. Contact information is on the flier.
Please contact us if you have questions or suggestions on how to get this message out to as many seniors as we can.
If you haven’t heard about our Alzheimer’s study and are interested in learning more, please contact us.
Visit this page again for updates on new clinical trials.